脐带血干细胞的基础与应用研究

sciential

7 s3 O+ p6 [, w/ o; v$ Z% W
! d: |7 @6 Z( \! @1 h# G+ z( ~
顾东生, 刘 斌, 韩忠朝*
  z0 X% ?7 q1 o  M（中国医学科学院中国协和医科大学血液学研究所实验血液学国家重点实验室，天津 300020）
* K; a6 ?3 |. Q& I2 h+ {! n摘　要：作为造血干/ 祖细胞(hematopoietic stem cells/hematopoietic progenitor cells, HSCs/HPCs)的另一
  u' O6 J8 J" E" K来源，脐带血已经应用于临床治疗多种恶性和非恶性疾病。脐带血中HSCs/HPCs 的质与量是决定其临
4 b+ C2 D6 L4 T# J7 p1 {床应用效果的最重要因素。同时，脐带血中还存在多种非造血的干细胞和前体细胞，如间充质干细胞
6 M5 R' W0 J) Q: T6 N(mesenchymal stem cells, MSCs)、内皮前体细胞(endothelial progenitor cells, EPCs)和非限制性体干细胞, F3 B/ U$ P9 x
(unrestricted somatic stem cells, USSCs)等，这些细胞可能会在未来的细胞治疗和再生医学中发挥重要作2 G! ^" [" C! f0 }! P0 B/ K
用。本综述还讨论了脐带血的临床应用及HSCs/HPCs 的体外扩增、增加HSCs 归巢和再植能力等提高
+ y0 V" U6 C2 d  D4 V% W5 v其临床应用能力的相关研究。' O4 K: U. u" r( D
关键词：脐带血；造血干细胞；移植: ^- S" |% {2 D7 C0 G) L
中图分类号：R322.2; R323.3; Q813　　文献标识码：A
$ D  p% {+ E4 t  o  ~4 e% Y: PThe research and application of cord blood stem cells
4 z; W' p1 Z9 J; Q9 W: u0 pGU Dong-Sheng, LIU Bin, HAN Zhong-Chao*( K, D& r  w8 @- U. J* R
(State Key Laboratory of Experimental Hematology, Institute of Hematology, Chinese Academy of2 L  ^6 a: z7 o, g! Z
Medical Sciences and Peking Union Medical College, Tianjin 300020, China)5 c2 W4 @# ?9 o! n' Y
Abstract: Umbilical cord blood (UCB), as an alternative source of hematopoietic/progenitor stem cells (HSCs/
% _: s. M9 [% _; Y4 V- o. gHPCs), has been used clinically for a large number of malignant and non-malignant disorders. The quality and2 f* Y" s6 s# I: j6 B
quantity of HSC and HPC may be the most important factors on which the capacity of UCB to perform clinical
6 h5 x7 |% y, g8 A* Q9 Mfunction depends. Other non-HSCs/HPCs, such as mesenchymal stem cells (MSCs), endothelial progenitor6 G/ S: p& f# Y! W& m
cells (EPCs) and unrestricted somatic stem cells (USSCs), also present in cord blood, which may play a future$ Y. _& o/ w; n6 j. _: S! o
role in cell therapy and regenerative medicine. This review also covers the efforts to expand HSCs and HPCs ex2 }' c! e$ p& l- |4 A) ~$ t  j
vivo and recent studies on attempts to enhance the homing and engrafting capability of HSCs as means to enhance
( v: @) b) E- s& p3 I4 K% ]3 pthe clinical utility of UCB.$ S0 o& [1 L+ M3 ~! F  _9 t% g
Key words: umbilical cord blood; hematopoietic stem cells; transplantation
' J2 P1 O) {4 V$ [5 d! Z
, j9 B, n" ]& r. h5 u& r; G附件为全文，请大家支持一下 回复本贴就可以下载了( E" h7 r1 {* Q% r, s- w6 H. {
2 C- n8 b% Z  T; k  V

gloria550

学习下，谢谢啦

yusheen

谢谢，学习下

xiaoheilong

看看

frli62

回复 1# sciential

frli62

回复 1# sciential
. y9 I. [/ o0 t, y* E! {: ^3 h( J' r! s7 s
ok

德德亦菲

不知道是不是新的文章，谢谢

德德亦菲

这篇06年的已经有了，呵呵。建议写上发表的年限

flyingpnmc

thanks

大漠

谢谢1